Cerity Partners LLC Baxter International Inc Transaction History

Cerity Partners LLC

  • $44.7 Billion
  • Q3 2024

A detailed history of Cerity Partners LLC transactions in Baxter International Inc stock. As of the latest transaction made, Cerity Partners LLC holds 97,878 shares of BAX stock, worth $2.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
97,878
Previous 82,563 18.55%
Holding current value
$2.8 Million
Previous $2.76 Million 34.59%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$32.85 - $40.26 $503,097 - $616,581
15,315 Added 18.55%
97,878 $3.72 Million
Q2 2024

Aug 13, 2024
SELL
$32.87 - $43.55 $567,566 - $751,977
-17,267 Reduced 17.3%
82,563 $2.76 Million
Q1 2024

May 14, 2024
BUY
$37.88 - $43.77 $2.82 Million - $3.26 Million
74,468 Added 293.62%
99,830 $4.27 Million
Q4 2023

Jan 26, 2024
BUY
$31.71 - $38.95 $496,546 - $609,918
15,659 Added 161.38%
25,362 $980,000
Q3 2023

Nov 13, 2023
SELL
$37.32 - $49.29 $993,794 - $1.31 Million
-26,629 Reduced 73.29%
9,703 $366,000
Q2 2023

Aug 14, 2023
BUY
$39.98 - $47.68 $268,305 - $319,980
6,711 Added 22.66%
36,332 $1.66 Million
Q1 2023

May 11, 2023
BUY
$37.58 - $52.57 $151,297 - $211,646
4,026 Added 15.73%
29,621 $1.2 Million
Q4 2022

Feb 15, 2023
BUY
$49.7 - $57.71 $128,226 - $148,891
2,580 Added 11.21%
25,595 $1.3 Million
Q3 2022

Nov 10, 2022
BUY
$53.86 - $66.8 $38,294 - $47,494
711 Added 3.19%
23,015 $1.24 Million
Q2 2022

Aug 10, 2022
BUY
$63.83 - $80.0 $355,533 - $445,600
5,570 Added 33.29%
22,304 $1.43 Million
Q1 2022

Apr 25, 2022
SELL
$76.85 - $89.45 $191,587 - $222,998
-2,493 Reduced 12.97%
16,734 $1.3 Million
Q4 2021

Feb 14, 2022
BUY
$74.57 - $87.19 $454,578 - $531,510
6,096 Added 46.42%
19,227 $1.65 Million
Q3 2021

Oct 25, 2021
SELL
$73.77 - $83.61 $98,704 - $111,870
-1,338 Reduced 9.25%
13,131 $1.06 Million
Q2 2021

Aug 11, 2021
SELL
$80.5 - $88.01 $96,278 - $105,259
-1,196 Reduced 7.63%
14,469 $1.17 Million
Q1 2021

Aug 11, 2021
SELL
$76.38 - $86.03 $88,371 - $99,536
-1,157 Reduced 6.88%
15,665 $1.32 Million
Q1 2021

May 12, 2021
SELL
$76.38 - $86.03 $117,014 - $131,797
-1,532 Reduced 8.35%
16,822 $1.42 Million
Q4 2020

Feb 11, 2021
BUY
$75.39 - $82.36 $112,406 - $122,798
1,491 Added 8.84%
18,354 $1.47 Million
Q3 2020

Nov 12, 2020
BUY
$78.33 - $90.73 $350,526 - $406,016
4,475 Added 36.12%
16,863 $1.36 Million
Q2 2020

Aug 14, 2020
BUY
$78.66 - $94.14 $74,176 - $88,774
943 Added 8.24%
12,388 $1.07 Million
Q1 2020

May 14, 2020
SELL
$71.57 - $93.3 $335,878 - $437,856
-4,693 Reduced 29.08%
11,445 $929,000
Q4 2019

Feb 14, 2020
SELL
$76.7 - $88.45 $84,983 - $98,002
-1,108 Reduced 6.42%
16,138 $1.35 Million
Q3 2019

Oct 30, 2019
BUY
$81.4 - $89.78 $550,752 - $607,451
6,766 Added 64.56%
17,246 $1.51 Million
Q2 2019

Aug 14, 2019
SELL
$73.44 - $82.41 $20,416 - $22,909
-278 Reduced 2.58%
10,480 $858,000
Q1 2019

May 14, 2019
SELL
$64.48 - $81.31 $456,453 - $575,593
-7,079 Reduced 39.69%
10,758 $875,000
Q4 2018

Feb 06, 2019
SELL
$61.45 - $77.8 $3,318 - $4,201
-54 Reduced 0.3%
17,837 $1.17 Million
Q3 2018

Nov 15, 2018
SELL
$70.71 - $77.75 $369,035 - $405,777
-5,219 Reduced 22.58%
17,891 $1.38 Million
Q2 2018

Aug 15, 2018
BUY
$63.43 - $75.41 $321,463 - $382,177
5,068 Added 28.09%
23,110 $1.71 Million
Q1 2018

May 15, 2018
SELL
$62.56 - $72.26 $234,975 - $271,408
-3,756 Reduced 17.23%
18,042 $1.17 Million
Q4 2017

Feb 14, 2018
SELL
$61.45 - $66.05 $619,846 - $666,246
-10,087 Reduced 31.64%
21,798 $1.41 Million
Q3 2017

Nov 13, 2017
BUY
$59.5 - $64.61 $1.9 Million - $2.06 Million
31,885
31,885 $2 Million

Others Institutions Holding BAX

# of Institutions
1,007
Shares Held
450M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email